India's benchmark indexes are likely to open little changed on Tuesday, after logging their best day in more than four years ...

(Reuters) -Indian pharmaceutical stocks shed 1.3% on Monday, even as the broader markets rose, after U.S. President Donald ...

Pharma sector stocks in the Indian stock market showed strong resilience on Monday despite initial pressure due to the ...

Indian pharmaceutical shares dropped up to 7% following US President Donald Trump's pledge to significantly lower US drug ...

Pharma stocks rise amid market drop due to limited impact from US pricing order. Discover more on what fuels this trend.

Pharma stocks lit up Dalal Street on Tuesday as President Donald Trumps remarks on drug pricing sent mixed signals to global ...

Sudarshan Pharma Industries Limited's board has resolved on May 13, 2025, to acquire 300 shares of Cibachem General Trading L ...

The Nifty Pharma Index ended 0.2% higher Monday after tumbling almost 2.4% earlier in the day in response to Trump's remarks.

Trump said he would introduce a “most favoured nation” (MFN) policy whereby the US pays “the same price as the nation that ...

US President Trump's move to cut drug prices by 30–80% may severely impact Indian pharma exports and profitability, ...

Trump said he would sign an executive order on Monday to pursue "most favored nation" pricing. The U.S. currently pays nearly ...

May 12 (Reuters) - Indian pharma stocks (.NIPHARM), opens new tab fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would cut drug prices by 30%–80% to match ...